[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.141.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 14, 2004

Evaluation of Drug Utilization Review Programs

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(2):184-185. doi:10.1001/jama.291.2.185-a

To the Editor. Dr Hennessy and colleagues1 concluded that "Given the lack of evidence for effectiveness and the suggestions from previous research for possible harm, policymakers should consider withdrawing the legislative mandate for retrospective drug use review." It is possible, however, that their negative results were related either to a lack of effectiveness of that particular intervention, or to inappropriate choice of outcome measures. Thus, we do not believe that their results warrant such a sweeping conclusion about drug utilization review in principle.

First Page Preview View Large
First page PDF preview
First page PDF preview
×